✦ LIBER ✦

Effective Targeting of Quiescent Chronic Myelogenous Leukemia Stem Cells by Histone Deacetylase Inhibitors in Combination with Imatinib Mesylate

✍ Scribed by Bin Zhang; Adam C. Strauss; Su Chu; Min Li; Yinwei Ho; Keh-Dong Shiang; David S. Snyder; Claudia S. Huettner; Leonard Shultz; Tessa Holyoake; Ravi Bhatia

Book ID: 113523945
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 1021 KB
Volume: 17
Category: Article
ISSN: 1535-6108
DOI: 10.1016/j.ccr.2010.03.011

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Imatinib mesylate is effective in childr

Imatinib mesylate is effective in children with chronic myelogenous leukemia in late chronic and advanced phase and in relapse after stem cell transplantation

✍ Millot, F; Guilhot, J; Nelken, B; Leblanc, T; De Bont, E S; Békassy, A N; Gadner 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 108 KB

Safety and efficacy of STI-571 (imatinib

Safety and efficacy of STI-571 (imatinib mesylate) in patients with bcr/abl-positive chronic myelogenous leukemia (CML) after autologous peripheral blood stem cell transplantation (PBSCT)

✍ Fischer, T; Reifenrath, C; Hess, G R; Corsetti, M T; Kreil, S; Beck, J; Meinhard 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 253 KB

Successful treatment of lymphoid blastic

Successful treatment of lymphoid blastic crisis in chronic myelogenous leukemia with the additional bcr/abl transcript using imatinib-combined chemotherapy and high-dose chemotherapy with allogeneic bone marrow stem cell transplantation

✍ Noriaki Kawano; Shinya Okuda; Shuro Yoshida; Hiroko Kugimiya; Masaki Ito; Nagako 📂 Article 📅 2011 🏛 Carden Jennings Publishing 🌐 English ⚖ 288 KB